KROS
Keros Therapeutics, Inc. SEC filings
Every EDGAR filing for Keros Therapeutics, Inc. (KROS), newest first, with AI summaries and stories.
- Ticker
- KROS
- CIK
- 1664710
- Sector
- Biotech and pharma
- Latest filing
- Sep 29
Next: earnings expected ~Nov 6 · 10-Q expected ~Nov 6 (deadline Nov 16)
Filings
8-KKeros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE EFFECTKeros Therapeutics, Inc.KROSLIVE DEL AMKeros Therapeutics, Inc.KROSLIVE S-3Keros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE 4Keros Therapeutics, Inc.KROSLIVE 4 insider filings
Annita Tanini, insider filing for KROS
Show all 4
- 4Insider filing for KROS
- 4Insider filing for KROS
- 4Insider filing for KROS
- 4Insider filing for KROS
Annita Tanini, reporting
4Keros Therapeutics, Inc.KROSLIVE Jean Jacques Bienaime, insider filing for KROS
Jean Jacques Bienaime, reporting
144Keros Therapeutics, Inc.KROSLIVE Charles W. Newton, planned sale of KROS shares
Charles W. Newton, reporting
3Keros Therapeutics, Inc.KROSLIVE Annita Tanini, new insider at KROS
Annita Tanini, reporting
8-KKeros Therapeutics, Inc.KROSLIVE 10-QKeros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE SCHEDULE 13G/AKeros Therapeutics, Inc.KROSLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
8-KKeros Therapeutics, Inc.KROSLIVE 4Keros Therapeutics, Inc.KROSLIVE Jean Jacques Bienaime, insider filing for KROS
Jean Jacques Bienaime, reporting
SCHEDULE 13GKeros Therapeutics, Inc.KROSLIVE Ownership stake disclosure by BlackRock Portfolio Management LLC
BlackRock Portfolio Management LLC, filed by
4Keros Therapeutics, Inc.KROSLIVE 2 insider filings
Anne Prener, insider filing for KROS
Show all 2
- 4Insider filing for KROS
- 3New insider at KROS
Anne Prener, reporting
8-KKeros Therapeutics, Inc.KROSLIVE 4Keros Therapeutics, Inc.KROSLIVE Jean Jacques Bienaime, insider filing for KROS
Jean Jacques Bienaime, reporting
4Keros Therapeutics, Inc.KROSLIVE Charles W. Newton, insider filing for KROS
Charles W. Newton, reporting
144Keros Therapeutics, Inc.KROSLIVE Charles W. Newton, planned sale of KROS shares
Charles W. Newton, reporting
4Keros Therapeutics, Inc.KROSLIVE 2 insider filings
Nima Farzan, insider filing for KROS
Show all 2
- 4Insider filing for KROS
- 4Insider filing for KROS
Nima Farzan, reporting
4Keros Therapeutics, Inc.KROSLIVE Alpna Seth, insider filing for KROS
Alpna Seth, reporting
4Keros Therapeutics, Inc.KROSLIVE 5 insider filings
Jean Jacques Bienaime, insider filing for KROS
Show all 5
- 4Insider filing for KROS
- 4Insider filing for KROS
- 4Insider filing for KROS
- 4Insider filing for KROS
- 4Insider filing for KROS
Jean Jacques Bienaime, reporting
144Keros Therapeutics, Inc.KROSLIVE 3 Form 144 notices
Nima Farzan, planned sale of KROS shares
Show all 3
- 144Planned insider sale of KROS shares
- 144Planned insider sale of KROS shares
- 144Planned insider sale of KROS shares
Nima Farzan, reporting
8-KKeros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE 4Keros Therapeutics, Inc.KROSLIVE Jean Jacques Bienaime, insider filing for KROS
Jean Jacques Bienaime, reporting
SCHEDULE 13GKeros Therapeutics, Inc.KROSLIVE Ownership stake disclosure by Nantahala Capital Management, LLC
Nantahala Capital Management, LLC, filed by
10-QKeros Therapeutics, Inc.KROSLIVE 8-KKeros Therapeutics, Inc.KROSLIVE ARSKeros Therapeutics, Inc.KROSLIVE DEFA14AKeros Therapeutics, Inc.KROSLIVE DEF 14AKeros Therapeutics, Inc.KROSLIVE 4Keros Therapeutics, Inc.KROSLIVE Jean Jacques Bienaime, insider filing for KROS
Jean Jacques Bienaime, reporting
SCHEDULE 13GKeros Therapeutics, Inc.KROSLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
4Keros Therapeutics, Inc.KROSLIVE Jasbir Seehra, insider filing for KROS
Jasbir Seehra, reporting